학술논문
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
Document Type
Article
Author
Source
In: Neuro-Oncology . (Neuro-Oncology, 1 September 2015, 17(9):1275-1283)
Subject
Language
English
ISSN
15235866
15228517
15228517